scispace - formally typeset
V

Vincent C. Tam

Researcher at Tom Baker Cancer Centre

Publications -  73
Citations -  4997

Vincent C. Tam is an academic researcher from Tom Baker Cancer Centre. The author has contributed to research in topics: Sorafenib & Hepatocellular carcinoma. The author has an hindex of 25, co-authored 60 publications receiving 4186 citations. Previous affiliations of Vincent C. Tam include University of Ottawa & University of Toronto.

Papers
More filters
Journal ArticleDOI

Unintended Medication Discrepancies at the Time of Hospital Admission

TL;DR: Better methods of ensuring an accurate medication history at the time of hospital admission are needed for patients reporting the use of at least 4 regular prescription medications who were admitted to general internal medicine clinical teaching units.
Journal ArticleDOI

Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review

TL;DR: Improved physician training, accessible community pharmacy databases and closer teamwork between patients, physicians and pharmacists could reduce the frequency of medication history errors at hospital admission.
Journal ArticleDOI

Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

TL;DR: Evidence is provided for the direct interaction of mu- and delta-opioid receptors to form oligomers, with the generation of novel pharmacology and G protein coupling properties.
Journal ArticleDOI

Genomewide identification of proteins secreted by the Hrp type III protein secretion system of Pseudomonas syringae pv. tomato DC3000.

TL;DR: Analysis of the enlarged collection of proteins traveling the Hrp pathway in P. syringae revealed an export-associated pattern of equivalent solvent-exposed amino acids in the N-terminal five positions, a lack of Asp or Glu residues in the first 12 positions, and amphipathicity in thefirst 50 positions, which was used to search the unfinished DC3000 genome.
Journal ArticleDOI

Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation.

TL;DR: Some of the findings from the animal model were recapitulated in studies of human nasopharyngeal lavages obtained during the 2009-2011 influenza seasons, and Hydroxylated linoleic acid was identified as a potential biomarker for immune status during an active infection.